THOUSAND OAKS, Calif.,
Dec. 3, 2018 /PRNewswire/
-- Amgen (NASDAQ:AMGN) will present at the Citi Global
Healthcare Conference at 12:35 p.m. ET on
Thursday, Dec. 6, 2018, in New
York City. Elliott M. Levy,
M.D., senior vice president of Global Development at Amgen, will
present at the conference. Live audio of the presentation can be
accessed from the Events Calendar on Amgen's website,
www.amgen.com, under Investors. A replay of the webcast will also
be available on Amgen's website for at least 90 days following the
event.
About Amgen
Amgen is committed to unlocking
the potential of biology for patients suffering from serious
illnesses by discovering, developing, manufacturing and delivering
innovative human therapeutics. This approach begins by using tools
like advanced human genetics to unravel the complexities of disease
and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and
leverages its expertise to strive for solutions that improve health
outcomes and dramatically improve people's lives. A biotechnology
pioneer since 1980, Amgen has grown to be one of the
world's leading independent biotechnology companies, has reached
millions of patients around the world and is developing a pipeline
of medicines with breakaway potential.
For more information, visit www.amgen.com and follow
us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand
Oaks
Kristen Davis, 805-447-3008
(Media)
Kristen Neese, 805-313-8267
(Media)
Arvind Sood, 805-447-1060
(Investors)
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-citi-global-healthcare-conference-300759267.html
SOURCE Amgen